Newcells Biotech kidney transporter assays provide robust, human-relevant platforms to evaluate renal drug transport mechanisms. Designed to assess uptake and efflux pathways, these assays support early ADME screening, DDI risk evaluation and renal clearance prediction, enabling researchers to generate reliable, reproducible data for informed compound optimization and regulatory confidence. For more visit us!
